Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise J Barber

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
DNA Repair|October 10, 2006
BRCA1 ubiquitylation of CtIP: Just the tIP of the iceberg?Louise J Barber, Simon J Boulton
Current Opinion in Genetics & Development|January 3, 2015
Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scaleLouise J Barber, Matthew N Davies, Marco Gerlinger
Mutation Research|December 9, 2008
C. elegans: a model of Fanconi anemia and ICL repairJillian L Youds, Louise J Barber, Simon J Boulton
Molecular and Cellular Biology|March 4, 2005
DNA interstrand cross-link repair in the Saccharomyces cerevisiae cell cycle: overlapping roles for PSO2 (SNM1) with MutS factors and EXO1 during S phaseLouise J Barber, Thomas A Ward, John A Hartley, et al.
The EMBO Journal|July 6, 2007
Replication blocking lesions present a unique substrate for homologous recombinationJordan D Ward, Louise J Barber, Mark Ir Petalcorin, et al.
Cancer Research Communications|November 22, 2023
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγAlice Newey, Lu Yu, Louise J Barber, et al.
DNA Repair|August 18, 2006
C. elegans FANCD2 responds to replication stress and functions in interstrand cross-link repairSpencer J Collis, Louise J Barber, Jordan D Ward, et al.
Trends in Cancer|March 8, 2016
Cancer Evolution and the Limits of Predictability in Precision Cancer MedicineKamil A Lipinski, Louise J Barber, Matthew N Davies, et al.
The EMBO Journal|September 26, 2009
The MRT-1 nuclease is required for DNA crosslink repair and telomerase activity in vivo in Caenorhabditis elegansBettina Meier, Louise J Barber, Yan Liu, et al.
EMBO Molecular Medicine|January 6, 2010
Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2Sarah A Martin, Afshan McCarthy, Louise J Barber, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
DNA Repair|October 10, 2006
BRCA1 ubiquitylation of CtIP: Just the tIP of the iceberg?Louise J Barber, Simon J Boulton
Current Opinion in Genetics & Development|January 3, 2015
Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scaleLouise J Barber, Matthew N Davies, Marco Gerlinger
Mutation Research|December 9, 2008
C. elegans: a model of Fanconi anemia and ICL repairJillian L Youds, Louise J Barber, Simon J Boulton
Molecular and Cellular Biology|March 4, 2005
DNA interstrand cross-link repair in the Saccharomyces cerevisiae cell cycle: overlapping roles for PSO2 (SNM1) with MutS factors and EXO1 during S phaseLouise J Barber, Thomas A Ward, John A Hartley, et al.
The EMBO Journal|July 6, 2007
Replication blocking lesions present a unique substrate for homologous recombinationJordan D Ward, Louise J Barber, Mark Ir Petalcorin, et al.
Cancer Research Communications|November 22, 2023
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγAlice Newey, Lu Yu, Louise J Barber, et al.
DNA Repair|August 18, 2006
C. elegans FANCD2 responds to replication stress and functions in interstrand cross-link repairSpencer J Collis, Louise J Barber, Jordan D Ward, et al.
Trends in Cancer|March 8, 2016
Cancer Evolution and the Limits of Predictability in Precision Cancer MedicineKamil A Lipinski, Louise J Barber, Matthew N Davies, et al.
The EMBO Journal|September 26, 2009
The MRT-1 nuclease is required for DNA crosslink repair and telomerase activity in vivo in Caenorhabditis elegansBettina Meier, Louise J Barber, Yan Liu, et al.
EMBO Molecular Medicine|January 6, 2010
Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2Sarah A Martin, Afshan McCarthy, Louise J Barber, et al.
Pageof 4